Inspirion Delivery Sciences LLC: MorphaBond ER™ US commercial launch Nov 2017 (FDA-approved, first single-entity abuse deterrent ER morphine product) and RoxyBond™ (FDA approved, first and only IR abuse-deterrent opioid product) both licensed to Daiichi Sankyo, Inc. Novel extended and immediate release technologies enable pain medications with abuse deterrent features, addressing the Opioid epidemic.
100 Southgate Parkway
Suite 150
Morristown, NJ 07960
United States

Send Message to Request Information

Log in to download presentation, request a 1x1 meeting, view additional roadshows, and more.